Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

EMERGENT BIOSOLUTIONS INC.

(EBS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Emergent BioSolutions Inc.
Emergent BioSolutions Inc. is a life sciences company. The Company focuses on protecting and enhancing life by providing specialty products for civilian and military populations that address accidental, intentional and naturally emerging public health threats. It focuses on developing, manufacturing and commercializing medical countermeasures that address public health threats (PHTs). The PHTs operates through two categories: Chemical, Biological, Radiological and Nuclear, as well as explosive-related threats and emerging infectious diseases. It operates through four business units: Vaccines and Anti-infectives; Antibody Therapeutics; Devices, and Contract Manufacturing. Vaccines and Anti-infectives business unit consists of BioThrax, which is for the general use prophylaxis and post-exposure prophylaxis of anthrax disease. Devices business unit consists of marketed products, such as Reactive Skin Decontamination Lotion Kit (RSDL) and Trobigard (atropine sulfate, obidoxime chloride).

Number of employees : 2 200 people.
Sales per Business
20192020Delta
Contract Development and Manufacturing80.007.2%450.5029% +463.13%
Anthrax Vaccines172.8015.6%373.8024% +116.32%
NARCAN Nasal Spray280.4025.4%311.2020% +10.98%
ACAM2000242.6021.9%200.3012.9% -17.44%
Contracts and Grants122.5011.1%115.107.4% -6.04%
Other207.7018.8%104.506.7% -49.69%
USD in Million
Sales per region
20192020Delta
United States995.4090%1 446.5293% +45.32%
International110.6010%108.887% -1.56%
USD in Million
Managers
Name Title Age Since
Robert Kramer President, Chief Executive Officer & Director 62 2019
Richard Lindahl Chief Financial Officer, Treasurer & Executive VP 56 2018
Sharon Solomon Chief Information Officer & Senior Vice President - 2017
Karen Smith Chief Medical Officer 52 2020
Christopher H. Cabell, Dr. Head-Clinical Development 51 -
Adam Havey Chief Operating Officer & Executive Vice President 49 2021
Laura Kennedy Senior VP, Chief Ethics & Compliance Officer - 2016
Zsolt Pál Harsányi, Dr. Independent Director 77 2011
Ronald B. Richard Lead Independent Director 64 2011
Louis Wade Sullivan, Dr. Independent Director 86 2006
Members of the board
Name Title Age Since
Fuad El Hibri Executive Chairman 62 2012
Robert Kramer President, Chief Executive Officer & Director 62 2019
Zsolt Pál Harsányi, Dr. Independent Director 77 2011
Ronald B. Richard Lead Independent Director 64 2011
Louis Wade Sullivan, Dr. Independent Director 86 2006
George A. Joulwan Independent Director 80 2013
Jerome M. Hauer, Dr. Independent Director 68 2015
Kathryn C. Zoon, Dr. Independent Director 71 2016
Marvin L. White Director 58 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 54,900,729 48,628,231 88.6% 1,200,000 2.2% 88.6%
Shareholders
NameEquities%
The Vanguard Group, Inc. 4,870,917 9.07%
Janus Capital Management LLC 3,648,969 6.80%
Neuberger Berman Investment Advisers LLC 3,418,606 6.37%
Fuad El Hibri 2,648,143 4.93%
Intervac LLC 2,140,463 3.99%
SSgA Funds Management, Inc. 2,131,463 3.97%
EARNEST Partners LLC 2,121,544 3.95%
Aberdeen Asset Managers Ltd. 1,737,470 3.24%
Scopia Capital Management LP 1,542,285 2.87%
BlackRock Fund Advisors 1,447,427 2.70%
Company contact information
Emergent BioSolutions, Inc.
400 Professional Drive
Suite 400
Gaithersburg, MD 20879

Phone : +1.240.631.3200
Fax : +1.240.631.3203
Web : http://www.emergentbiosolutions.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Emergent BioSolutions Inc.
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
EMERGENT BIOSOLUTIONS INC.-36.23%3 068
JOHNSON & JOHNSON4.68%434 939
ROCHE HOLDING AG11.70%327 062
PFIZER, INC.20.81%249 329
NOVO NORDISK A/S51.34%233 887
ELI LILLY AND COMPANY36.28%209 456
ABBVIE INC.0.54%190 996
NOVARTIS AG-6.89%188 323
MERCK & CO., INC.-12.02%182 183
ASTRAZENECA PLC10.09%173 735
BRISTOL-MYERS SQUIBB COMPANY-1.16%136 060
AMGEN INC.-4.58%123 428
SANOFI3.62%120 604
GLAXOSMITHKLINE PLC3.44%96 182
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-23.73%61 871
TAKEDA PHARMACEUTICAL COMPANY LIMITED1.54%54 198
BAYER AG-6.12%52 750
DAIICHI SANKYO COMPANY, LIMITED-20.66%48 385
JIANGSU HENGRUI MEDICINE CO., LTD.-49.45%45 545
ASTELLAS PHARMA INC.18.51%31 807